Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association
SR El Khoudary, B Aggarwal, TM Beckie, HN Hodis… - Circulation, 2020 - Am Heart Assoc
Cardiovascular disease (CVD) is the leading cause of death in women, who have a notable
increase in the risk for this disease after menopause and typically develop coronary heart …
increase in the risk for this disease after menopause and typically develop coronary heart …
[HTML][HTML] Epidemiology of ovarian cancer: a review
BM Reid, JB Permuth, TA Sellers - Cancer biology & medicine, 2017 - ncbi.nlm.nih.gov
Ovarian cancer (OC) is the seventh most commonly diagnosed cancer among women in the
world and the tenth most common in China. Epithelial OC is the most predominant …
world and the tenth most common in China. Epithelial OC is the most predominant …
Ovarian cancer: epidemiology, biology, and prognostic factors
CH Holschneider, JS Berek - Seminars in surgical oncology, 2000 - Wiley Online Library
Ovarian cancer varies widely in frequency among different geographic regions and ethnic
groups, with a high incidence in Northern Europe and the United States, and a low …
groups, with a high incidence in Northern Europe and the United States, and a low …
Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone
HA Risch - Journal of the National Cancer Institute, 1998 - academic.oup.com
Abstract In the United States, ovarian cancer is the fourth most frequent cause of cancer
death among women, following lung, breast, and colorectal cancers. Each year …
death among women, following lung, breast, and colorectal cancers. Each year …
Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis
LJ Havrilesky, PG Moorman, WJ Lowery… - Obstetrics & …, 2013 - journals.lww.com
OBJECTIVE: To estimate the overall reduction in ovarian cancer risk associated with the use
of oral contraceptive pills (OCPs) and whether reduction in risk is affected by specifics of …
of oral contraceptive pills (OCPs) and whether reduction in risk is affected by specifics of …
[HTML][HTML] Oral contraceptives and the risk of hereditary ovarian cancer
Background Women with mutations in either the BRCA1 or the BRCA2 gene have a high
lifetime risk of ovarian cancer. Oral contraceptives protect against ovarian cancer in general …
lifetime risk of ovarian cancer. Oral contraceptives protect against ovarian cancer in general …
Epidemiology of ovarian cancer
J Permuth-Wey, TA Sellers - Cancer epidemiology: modifiable factors, 2009 - Springer
Ovarian cancer represents the sixth most commonly diagnosed cancer among women in the
world, and causes more deaths per year than any other cancer of the female reproductive …
world, and causes more deaths per year than any other cancer of the female reproductive …
Parity, age at first childbirth, and risk of ovarian cancer
Increasing parity is associated with a reduction in the risk of ovarian cancer, but it is not clear
whether this association applies to different histopathological types and to borderline …
whether this association applies to different histopathological types and to borderline …
Endogenous hormones and ovarian cancer: epidemiology and current hypotheses
A Lukanova, R Kaaks - Cancer Epidemiology Biomarkers & Prevention, 2005 - AACR
The effect of major epidemiologic risk factors for ovarian cancer has been reviewed in the
light of several hormonal hypotheses, including the gonadotropin, androgens, progesterone …
light of several hormonal hypotheses, including the gonadotropin, androgens, progesterone …
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review for the US Preventive Services Task …
Background: Clinically significant mutations of BRCA1 and BRCA2 genes are associated
with increased susceptibility for breast and ovarian cancer. Although these mutations are …
with increased susceptibility for breast and ovarian cancer. Although these mutations are …